Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
RESEARCH TOOLSreports
Holding TSE:HLS?
Track your performance easily
HLS Therapeutics Inc (HLS) Ownership Overview
61.73% Insiders
0.01% Mutual Funds
1.61% Other Institutional Investors
36.64% Public Companies and
Individual Investors
The ownership structure of HLS Therapeutics Inc (TSE:HLS) stock is a mix of institutional, retail and individual investors. Approximately 1.63% of the company’s stock is owned by Institutional Investors, 61.73% is owned by Insiders and 36.64% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 15, 2024 | John Gordon Hanna Interim Chief Financial Officer | xxxxxxxxxxxxx | C$12760 |
| May 17, 2024 | Craig Millian Chief Executive Officer | xxxxxxxxxxxxx | $7250 |
| Nov 18, 2023 | Craig Millian Chief Executive Officer | xxxxxxxxxxxxx | $13000 |
| Nov 16, 2023 | Brian Thomas Walsh Divisional Senior Vice President | xxxxxxxxxxxxx | $3494 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,367,082 | Insider | 20.03% | 21,648,079 | |
| 3,051,782 | Insider | 9.60% | 10,376,059 | |
| 2,473,615 | Insider | 7.78% | 8,410,291 | |
| 2,034,062 | Insider | 6.40% | 6,915,811 | |
| 1,900,000 | Insider | 5.98% | 6,460,000 | |
| 927,000 | Insider | 2.92% | 3,151,800 | |
| 838,575 | Insider | 2.64% | 2,851,155 | |
| 637,800 | Insider | 2.01% | 2,168,520 | |
| 378,070 | Insider | 1.19% | 1,285,438 | |
| 301,854 | Insider | 0.95% | 1,026,304 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,600 | Institution | <0.01% | 6,497 | |
| 1,000 | Institution | <0.01% | 2,499 | |
| 700 | Institution | <0.01% | 1,749 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,526 | Institution | 0.04% | 45,583 |
FAQ
Who Owns HLS Therapeutics Inc (TSE:HLS)?
According to the latest TipRanks data, approximately 1.61% of the company's stock is held by institutional investors, 61.73% is held by insiders, and 36.64% is held by retail investors.
What percentage of HLS Therapeutics Inc (TSE:HLS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.61% of HLS Therapeutics Inc (TSE:HLS) stock is held by institutional investors.
What percentage of HLS Therapeutics Inc (TSE:HLS) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.64% of HLS Therapeutics Inc (TSE:HLS) stock is held by retail investors.
Who owns the most shares of HLS Therapeutics Inc (TSE:HLS)?
Polar Securities Inc. owns the most shares of HLS Therapeutics Inc (TSE:HLS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.